Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fraser Wright

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Human Gene Therapy|May 15, 2009
Transient transfection methods for clinical adeno-associated viral vector productionJ Fraser Wright
Human Gene Therapy|August 24, 2011
Adeno-associated viral vector manufacturing: keeping pace with accelerating clinical developmentJ Fraser Wright
Biotechnology Journal|November 4, 2020
Quality Control Testing, Characterization and Critical Quality Attributes of Adeno-Associated Virus Vectors Used for Human Gene TherapyJ Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2023
Re-administration of AAV vectors by masking with host albumin: A Goldilocks hypothesisJ Fraser Wright
Biomedicines|May 27, 2017
Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk AssessmentJ Fraser Wright
Molecular Therapy. Methods & Clinical Development|August 28, 2023
Erratum: AAV vector production: Troublesome host innate responses in another settingJ Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 20, 2022
AAV vector manufacturing process design and scalability - Bending the trajectory to address vector-associated immunotoxicitiesJ Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2014
AAV empty capsids: for better or for worse?J Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2020
Quantification of CpG Motifs in rAAV Genomes: Avoiding the TollJ Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2020
Codon Modification and PAMPs in Clinical AAV Vectors: The Tortoise or the Hare?J Fraser Wright
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Human Gene Therapy|May 15, 2009
Transient transfection methods for clinical adeno-associated viral vector productionJ Fraser Wright
Human Gene Therapy|August 24, 2011
Adeno-associated viral vector manufacturing: keeping pace with accelerating clinical developmentJ Fraser Wright
Biotechnology Journal|November 4, 2020
Quality Control Testing, Characterization and Critical Quality Attributes of Adeno-Associated Virus Vectors Used for Human Gene TherapyJ Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2023
Re-administration of AAV vectors by masking with host albumin: A Goldilocks hypothesisJ Fraser Wright
Biomedicines|May 27, 2017
Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk AssessmentJ Fraser Wright
Molecular Therapy. Methods & Clinical Development|August 28, 2023
Erratum: AAV vector production: Troublesome host innate responses in another settingJ Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 20, 2022
AAV vector manufacturing process design and scalability - Bending the trajectory to address vector-associated immunotoxicitiesJ Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2014
AAV empty capsids: for better or for worse?J Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2020
Quantification of CpG Motifs in rAAV Genomes: Avoiding the TollJ Fraser Wright
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2020
Codon Modification and PAMPs in Clinical AAV Vectors: The Tortoise or the Hare?J Fraser Wright
Pageof 7